Andere Sprachen Bio-Techne Corporation

Aktien

A12ENG

US09073M1045

TECH

Realtime-Estimate Cboe BZX Andere Börsenplätze 20:31:38 19.04.2024			% 5 Tage	% 1. Jan.
62.17 ^USD	-0.06%		-6.47%	-19.12%

18.04.	BIO-TECHNE CORPORATION : Deutsche Bank Securities bleibt neutral	ZM
08.04.	BIO-TECHNE CORPORATION : RBC Capital Markets gibt neutrale Bewertung ab	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS	10.04.
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY	08.04.
BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS	01.04.
Bio-Techne Positioned for Growth Amid Biotech Funding Recovery, UBS Says	28.03.
BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES	28.03.
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA	25.03.
Bio-Techne Says European Union IVDR Certification Received for Diagnostic Test Tracking Chronic Myeloid Leukemia	22.03.
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA	22.03.
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES AND MEDTECH INVESTOR FORUM	13.03.
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM	12.03.
BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE	06.03.
Année faste en 2023 pour les levées de fonds à l'EPFL	12.02.
North American Morning Briefing : Hopes of March -2-	05.02.
Bio-Techne Seeks M&A	01.02.
Bio-Techne's Fiscal Q2 Adjusted Earnings Fall, Net Sales Rise	01.02.
Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q2 Revenue $272.6M, vs. Street Est of $277.7M	01.02.
BIO-TECHNE DECLARES DIVIDEND	01.02.
BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS	01.02.
Bio-Techne Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	01.02.
Bio-Techne Corporation Announces to Pay A Dividend for the Quarter Ended December 31, 2023, Payable February 26, 2024	01.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bio-Techne Corporation

Aktien

A12ENG

US09073M1045

TECH

Andere Sprachen

Filter